Company Filing History:
Years Active: 2010-2011
Title: Chris Ruf: Innovator in Lancet Technology
Introduction
Chris Ruf is a notable inventor based in Marietta, GA, United States. With a strong dedication to innovation in medical technology, Chris holds two patents that focus on advancements in lancet systems, particularly for blood glucose measurement.
Latest Patents
Chris Ruf's most recent patents include the lancet sensor assembly and meter. The first patent describes a method of obtaining a test sample from a specimen using a sophisticated lancet system, which features a lancet driver that engages with a drive wing of the lancet system. The system is designed with a sinuous portion of the lancet member that remains non-compressible when positioned in the lancet carrier, ensuring precise operation. The invention guarantees that the lancet tip can move from a retracted to an extended position smoothly, allowing for reliable sample collection.
The second patent, also titled lancet sensor assembly and meter, represents a blood glucose measuring system that incorporates a lancet assembly. This system includes an elongated carrier that houses the lancet member and features a lancet trigger alongside a measuring circuit. These innovations are crucial for enhancing the accuracy and efficiency of blood glucose monitoring, which is vital for many diabetic patients.
Career Highlights
Throughout his career, Chris Ruf has demonstrated a commitment to pushing the boundaries of medical device technology. His work at Nova Biomedical Corporation has been instrumental in developing inventive solutions that cater to the needs of clinicians and patients alike.
Collaborations
Chris has collaborated with talented colleagues such as James E Fowler and Robert Daggett, contributing to an environment of innovation and shared expertise. Their teamwork has helped refine the technologies they are working to improve, reinforcing Chris's role as an influential figure in medical device innovation.
Conclusion
As an inventor, Chris Ruf continues to impact the field of medical technology through his patents and collaborative efforts at Nova Biomedical Corporation. His contributions to lancet technology not only advance the accuracy of blood glucose monitoring but also enhance overall patient care. Chris's dedication to innovation and collaboration ensures that he remains a key player in the ongoing development of medical devices.